1AD
Click for more information
8.33% 2.6¢ adalta limited

Ann: AD-214 Phase I extension clinical study - interim results, page-15

  1. abcdefg
    725 Posts.
    lightbulb Created with Sketch. 49
    clock Created with Sketch.
    11/12/23
    15:06
    Post #: 71386266
    stage 1 in health patients leads to stage1 in sick and many fibrosis drugs get approval at stage 1 due to being such a horrible disease with no cure, it will most likely be a binary out come and if you're in you get upside and if you are not a holder you miss it - assuming it works that is
    1AD Price at posting: 2.3¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.6¢ 		Change
0.002(8.33%) 		Mkt cap ! $15.48M
Open High Low Value Volume
2.6¢ 2.6¢ 2.6¢ $8.093K 311.2K

Buyers (Bids)

No. Vol. Price($)
4 554539 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 400000 2
View Market Depth
Last trade - 11.36am 26/07/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.